DNAnexus: Funding, Investors & Team (Oct 2026)
DNAnexus develops a cloud platform and global network designed for scientific collaboration and accelerated discovery. It provides security, scalability, and collaboration for enterprises and organizations that are pursuing genomic-based approaches to health in order to accelerate medical discovery. DNAnexus is supporting customers around the world that are tackling some of the most challenging and exciting opportunities in human health. The company was founded in 2009 and is based in Mountain View, California.
DNAnexus has raised $300M across 2 funding rounds on record, the most recent a Series H of $200M announced in Mar 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
DNAnexus Company Profile and Key Stats
Latest funding round on record: Mar 2022.
DNAnexus Funding Rounds
DNAnexus raised $100M in an undisclosed round announced in Jun 2020.
1.8 years later, a Series H of $200M was announced in Mar 2022.
DNAnexus Founders and Leadership Team
Contact details for the DNAnexus team: 1 of 1 has an email address on file.
Start 14-day free trial →DNAnexus Funding Compared to Other Biotechnology Startups
DNAnexus' latest round of $200M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like DNAnexus in Biotechnology and Mountain View
Companies Similar to DNAnexus
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
DNAnexus Funding FAQs
What does DNAnexus do?
DNAnexus develops a cloud platform and global network designed for scientific collaboration and accelerated discovery. It provides security, scalability, and collaboration for enterprises and organizations that are pursuing genomic-based approaches to health in order to accelerate medical discovery. DNAnexus is supporting customers around the world that are tackling some of the most challenging and exciting opportunities in human health. The company was founded in 2009 and is based in Mountain View, California.
How much funding has DNAnexus raised?
DNAnexus has raised $300M across 2 rounds on record. The most recent is a Series H of $200M announced in Mar 2022.
When did DNAnexus last raise funding?
DNAnexus' most recent funding round on record is a Series H of $200M, announced in Mar 2022.
Who is the CEO of DNAnexus?
Richard Daly is listed as CEO at DNAnexus.
Where is DNAnexus headquartered?
DNAnexus is based in Mountain View, California, United States.
How many employees does DNAnexus have?
DNAnexus is in the 101-250 employee band.
How does DNAnexus' funding compare to other Biotechnology startups?
DNAnexus' latest round of $200M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's DNAnexus Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for DNAnexus is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.